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http:WHAT THIS PAPER ADDS
This study presents the ﬁrst analysis of the prevalence of familial abdominal aortic aneurysm (AAA) based on
population screening. Screening for AAA is not yet available in Denmark. It is the authors’ hope that this study
will help in the process of making screening an option in Denmark and that individuals with a known family
history of AAA might be included.Objective: To investigate, at a population level, whether a family history of abdominal aortic aneurysm (AAA) is
independently related to increased aortic diameter and prevalence of AAA in men, and to elucidate whether the
mean aortic diameter and the prevalence of AAA are different between participants with male and female
relatives with AAA.
Design: Observational population-based cross-sectional study.
Materials: 18,614 male participants screened for AAA in the VIVA-trial 2008e2011 with information on both
family history of AAA and maximal aortic diameter.
Methods: Standardized ultrasound scan measurement of maximum antero-posterior aortic diameter. Family
history obtained by questionnaire. Multivariate regression analysis was used to test for confounders: age, sex,
smoking, comorbidity and medication.
Results: From the screened cohort, 569 participants had at least one ﬁrst degree relative diagnosed with AAA,
and 38 had AAA. Participants with a family history of AAA (þFH) had a signiﬁcantly larger mean maximum aortic
diameter (20.50 mm) compared with participants without family history of AAA (FH) (19.07 mm, p < .0001),
and þFH with female relatives with AAA had signiﬁcantly larger mean maximum aortic diameter (21.8 mm)
than þFH with male relatives (19.9 mm, p ¼ .007). Furthermore the prevalence of AAA was signiﬁcantly higher
among þFH (6.7%) compared with FH (3.0%) with an odds ratio (OR) of 2.2 (95% CI: 1.6 to 3.2, p < .001)
and þFH with female relatives with AAA had a more than two and a half times increased prevalence of AAA
compared with þFH with male relatives with AAA with an OR of 2.65.
Conclusions: First-degree male relatives of AAA patients have wider aortas and a twofold higher prevalence of
AAA compared with the age adjusted background population. The prevalence of AAA was markedly higher in
participants related to female, rather than male, patients with AAA.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Relatives of patients with aortic aneurysms have a higher
risk of developing aneurysms themselves,1e11 but so far it
has not been possible to identify a pathophysiological
explanation for this. Although genetic susceptibility may
be suspected, it is also well known that individuals withrresponding author. T.M.M. Joergensen, Department of Vascular
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//dx.doi.org/10.1016/j.ejvs.2014.09.005ﬁrst degree relatives with abdominal aortic aneurysms
(AAA) have common environmental exposures and cultural
habits that may also cause the association. Age, smoking,
comorbidity, and use of medication are possible con-
founders that have hitherto not been subject to multi-
variate analyses. Earlier studies have not ruled out the
possibility of clustering of hypertension or smoking pat-
terns within families as causes of the increased likelihood
of AAA in siblings.2 Another question regarding the he-
redity of aneurysms is whether the prevalence of AAA is
different among participants who have a female relative
with AAA compared with participants who have a male
relative with AAA.
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individuals with a family history of the disease show signs of
predisposition to the development of AAA by having a
larger average abdominal aortic diameter than individuals
without a family history of AAA, 2) whether a family history
of AAA is related to a higher prevalence of the disease
independently of common confounding risk factors, and 3)
whether the prevalence of AAA is different for men who
have a female relative with AAA compared with those who
have a male relative with AAA.
MATERIALS AND METHODS
This study is a registry based study of male participants
with and without AAA, who had an abdominal ultrasound
scan during the VIVA-trial from 2008 to 2011. The details
of the VIVA-trial have been published previously.12 In
short, it is a randomized, clinically controlled study
designed to evaluate the beneﬁts of vascular screening
and modern vascular secondary prevention in a population
of men aged 65e74 years. A total of 50,309 men aged
65e74 years in the mid-region of Denmark qualiﬁed for
inclusion. Participants were randomized to either
screening or control groups. An invitation letter and pa-
tient information sheet were posted to all participants
allocated to screening. One re-invitation was sent to non-
responders. No ﬁnancial remuneration or alternative in-
centives were offered. The study was approved by the
local scientiﬁc ethical committee, and all participants
provided their informed consent.
According to randomization, 25,095 men were offered
vascular screening including ultrasound scan of the aorta
at their local hospital. Maximum aortic diameter was
measured with two-dimensional ultrasound (US) using a
Logiq e 4 MHz ultrasound transducer (General Electrics,
Fairﬁeld, CT, USA) placed longitudinally just above and to
the left of the umbilicus. In cases of dilatation of the
abdominal aorta, the maximal perpendicular antero-
posterior inner to inner aortic diameter was measured.
In cases where no dilatation was found, the antero-
posterior inner to inner aortic diameter was measured
2 cm above the bifurcation. AAA was deﬁned as
maximum aortic diameter 30 mm and sub-aneurysmal
dilatation as maximum diameter between 25 and
29 mm. Before undergoing the scan, the study partici-
pants completed a questionnaire (which was included in
the invitation letter) regarding family history, lifestyle
parameters and medical and smoking status (Appendix 1).
The questionnaire was created speciﬁcally for this
screening project and included the possibility of ticking
more boxes regarding family history, which in some cases
resulted in the sum of answers being greater than the
number of participants.Statistical analysis
For the present analysis, þFH participants were deﬁned as
those with at least one ﬁrst degree relative with AAA,and FH participants as those without any ﬁrst degree
relative with AAA. Analysis was performed using SPSS
(Version 12, SPSS Inc, Chicago, IL, USA) according to a
predeﬁned analysis plan. Only participants with information
on both aortic diameter and family history were included
(see Fig. 1). The mean aortic diameter was calculated for
both þFH and FH. Subgroup analysis was carried out
for þFH with female versus male relatives with AAA, as well
as for þFH without aneurysm at the time of screening
compared with the whole group. An additional post hoc
analysis was performed for participants with sub-
aneurysmal dilatation. Categorical variables were tested
by chi-square tests with results given as odds ratios (OR)
and continuous variables with unpaired Student t test. Us-
ing multivariate linear regression analysis, the results were
adjusted for potential confounding of age, sex, smoking,
comorbidity (diabetes, hypertension, peripheral arterial
disease), and medication (ACE-inhibitors, beta-blockers,
acetylsalicylic acid [ASA], and statins). All known con-
founders were included in the analysis even if they were not
individually signiﬁcant and tests were done for interactions
between variables. Values were expressed as
mean  standard deviation (SD), with 95% conﬁdence in-
tervals (CI). Any p value <.05 was considered statistically
signiﬁcant.
RESULTS
Participants with information on both maximum aortic
diameter and family history of the disease were included
(18,614, see Fig. 1). Among the included participants, 569
(3.1%) had at least one ﬁrst degree relative with AAA and a
total of 575 participants (3.1%) were diagnosed with AAA
and a further 491 (2.6%) had sub-aneurysmal enlargement
(25e29 mm). The proportion of þFH with AAA was 6.7%
(38/569) compared with 3.0% (537/18,045) of FH,
resulting in an OR of 2.2 (95% CI: 1.6 to 3.2, p < .001). Sub-
aneurysmal enlargement was present in 4.0% (23/569)
of þFH versus 2.6% (468/18 045) of FH giving an OR of 1.6
(95% CI: 1.08 to 2.53, p < .001).
Overall mean maximum aortic diameter for þFH was
20.50 mm (95% CI: 19.91 to 21.08) compared with
19.07 mm (95% CI: 18.99 to 19.14) for FH. Including only
participants without aneurysms, similar results were found:
19.01 mm (95% CI: 18.72 to 19.29) for þFH and 18.36 mm
(95% CI: 18.32 to 18.40) for FH. The results were similar
when looking at only patients with maximum aortic diam-
eter <25 mm: 18.64  2.6 mm among þFH and
18.22  2.4 mm among FH (p ¼ .0001). The signiﬁcant
ﬁndings mentioned above remained statistically signiﬁcant
after testing for confounders (age, body mass index, hy-
pertension, diabetes, and treatment with statins, ASA, or
anti-hypertensive medications) (see Table 3).
Considering only participants with aneurysms, no signif-
icant difference in diameter was found between þFH
(40.72  12.4 mm) and FH (40.32  12.0 mm; p ¼ .844).
Regarding comorbidities, signiﬁcantly increased preva-
lence was found among þFH with regard to hypertension
Figure 1. Flow diagram. 1Subjects who did not show up for screening. 2Subjects without information on family history or aortic diameter.
3Subjects with information on both family history (FH) and aortic diameter measured by ultrasound (US). þFH: Subjects with a positive
family history of abdominal aortic aneurysm (AAA). FH: Subjects with no known family history of AAA.
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11%, p ¼ .022) and smoking (25 vs. 21%, p ¼ .027), but not
diabetes (11% in both groups, p ¼ .748) (see Table 1 for
details).
Of the þFH with AAA, 16 had a brother diagnosed with
AAA, ten had a sister with AAA, ﬁve had a father with AAA,
and nine had a mother with AAA. One participant had both
a sister and a mother with AAA, and one participant had
both a male and a female relative with AAA. No participants
had both brother and father as relatives with AAA (see
Table 2 for OR for AAA in relation to the family history of
AAA). No further subgroup analysis was done regarding OR
for the single patient with both a male and a female relative
with AAA.
Both þFH with female and þFH with male relatives
with AAA had higher prevalence of AAA compared
with FH, with an OR of 4.32 (95% CI: 2.62 to 7.11)for þFH with female relatives and an OR of 1.61 (95% CI:
1.03 to 2.62) for þFH with male relatives. þFH with fe-
male relatives with AAA had a more than two-and-a-half
times increased risk of having an AAA compared
with þFH with male relatives with AAA with an OR of 2.65
(95% CI: 1.37 to 5.13).
Overall mean maximum aortic diameter for þFH with
male relatives with AAA was 20.09  5.85 mm compared
with 19.09  5.25 mm in participants without male rela-
tives with AAA (p < .001). Considering only participants
without aneurysms, similar results were found:
19.00 mm  2.99 mm in participants with male relatives
with AAA compared with 18.37 mm  2.81 mm in partici-
pants without male relatives with AAA (p < .001). Consid-
ering only participants with aneurysms, no signiﬁcant
difference was found with a mean aortic diameter of
40.37  11.71 mm in participants with male relatives with
Table 1. Patient characteristics, comorbidity and medication.
þFH with AAA
n ¼ 38
þFH without AAA
n ¼ 531
FH with AAA
n ¼ 537
FH without AAA
n ¼ 17 508
Age (years), median (25%; 75% percentiles) 70
(67; 72)
69
(67; 72)
70
(68; 72)
69
(67; 72)
Hypertension, n/N (%) 16/38 (42) 251/528 (47) 292/535 (55) 7,318/17,457 (42)
Diabetes, n/N (%) 3/38 (8) 57/531 (11) 59/536 (11) 1,900/17,493 (11)
Current smokers, n/N (%) 17/38 (45) 124/531 (23) 223/537 (42) 3,548/17,494 (20)
PAD, n/N (%) 8/38 (21) 71/539 (13) 151/532 (28) 1,801/17,476 (10)
Use of statins, n/N (%) 20/37 (54) 210/505 (42) 286/532 (54) 5,878/16,906 (35)
Use of ASA, n/N (%) 21/38 (55) 190/513 (37) 266/532 (50) 5,488/17,063 (32)
Use of ACE inhibitors, n/N (%) 6/38 (16) 126/500 (25) 143/527 (27) 3,485/16,866 (21)
Use of beta blockers, n/N (%) 10/38 (26) 112/500 (22) 157/525 (30) 3,055/16,836 (18)
AAA ¼ abdominal aortic aneurysm, maximum aortic diameter 30 mm; hypertension ¼ participants with diagnosed hypertension;
PAD ¼ peripheral arterial disease; ASA ¼ acetylsalicylic acid; N ¼ total number of participants with information.
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without male relatives with AAA (p ¼ .79).
The most marked difference was found when looking at
the impact of having a female relative with AAA: overall
mean maximum aortic diameter in participants with a fe-
male relative with AAA was 21.82  5.85 mm compared
with 19.09  5.20 mm in participants without female rel-
atives with AAA (p ¼ .001). þFH with AAA among female
relatives also had signiﬁcantly wider aortas
(21.8  7.2 mm) than þFH with male relatives with AAA
(19.9  5.5 mm, p ¼ .007), and the mean size of AAA was
12% larger in þFH with female relatives with AAA
(43.1 mm) compared with þFH with male relatives with
AAA (38.6 mm). This ﬁnding, however, was not signiﬁcant
(p ¼ .25).
DISCUSSION
In this study, an increased mean maximum infrarenal aortic
diameter was found among þFH compared with FH,
which was not explained by the higher risk factor proﬁle
found in þFH or by the larger number of AAA and sub-
aneurysmal enlargement found in this group. Increased
prevalence of AAA was also found among þFH, with the
highest prevalence of AAA among those with an affected
female relative.Table 2. Odds ratio (OR) for AAA in relation to family history.
AAA
(n AAA/n group) %
OR 95% CI p
Male
relative
Yes (21/436) 4.8 1.61 1.03 to 2.52 .037
No (554/18,178) 3.0
Female
relative
Yes (18/152) 11.8 4.32 2.62 to 7.11 <.001
No (557/18,462) 3.0
þFH (all) Yes (38/569) 6.7 2.2 1.6 to 3.2 <.001
No (537/18,045) 3.0
OR ¼ odds ratio; CI ¼ conﬁdence interval; AAA ¼ abdominal aortic
aneurysm, maximum aortic diameter 30 mm. Note: Numbers for
male þ female s all, as one participant had both a male and a
female relative with AAA.Although some of the difference in both prevalence of
AAA and the generally increased diameter among relatives
with the disease may be explained by common environ-
mental factors, a genetic cause is commonly suspected. This
notion seems to be supported by a recent study from the
Swedish twin registry, showing a higher concordance rate
among monozygotic than dizygotic twins.13 Formal statisti-
cal testing of the signiﬁcance of confounders is often difﬁ-
cult because of small sample sizes. In the present study, the
statistical strength of a large population based study was
increased by studying aortic diameter below the threshold
of diagnosing an aneurysm. This is considered prudent
because of the progressive nature of the condition. Using
this method, it was possible to include a high number of
individuals in our analysis. The fact that aortic diameter was
found to be larger among relatives of patients with AAA
even after considering relevant confounders, supports the
presence of an independent genetic component in the
aetiology of AAA.
Furthermore, this study presents the ﬁrst analysis of the
prevalence of familial AAA based on population screening,
as previous studies have based screening on families with
an already diagnosed AAA. The 6.7% prevalence of AAA
among ﬁrst degree relatives of AAA patients found in the
present study is lower than that found in earlier studies
using US examinations. This may reﬂect different patterns of
selection bias, information bias (as not all relatives have
been examined), bona ﬁde differences in prevalence be-
tween geographical regions, or possibly an overall decrease
in prevalence of AAAs over time.
The true prevalence of aortic aneurysms in ﬁrst degree
relatives is disputed, or may be different in different
populations. Investigators who either performed ultra-
sound screening of siblings of known probands or in-
terviews with known probands or both,1e11 reported the
overall prevalence among siblings to be between 10%1 and
25%.8 Johansen and Koepsell found a prevalence among
ﬁrst degree relatives of 19.2%, representing an 11.6 fold
increase in risk compared with controls.11 Using interviews
alone, Baird found only 4.4% of siblings of ﬁrst degree
Table 3. Mean maximum aortic diameter.
Group (N) Total mean diameter,
mean, mm (N)
Aortic diameter
30 mm, mean,
mm (N)
Aortic diameter
<30 mm, mean,
mm (N)
Aortic diameter
25e29 mm,
mean, mm (N)
Aortic diameter
<25 mm, mean,
mm (N)
% with
AAA
OR of
having AAA
þFH
N ¼ 569
20.50
(569)
40.72
(38)
19.01
(531)
26.32
(23)
18.64
(508)
6.7 2.2
(1.6 to 3.2)
FH
N ¼ 18,045
19.07
(18,045)
40.32
(537)
18.36
(17,508)
26.71
(468)
18.22
(17,040)
3.0 Reference
Comparison p < .0001
pa < .0001
p ¼ .844
pa ¼ .712
p < .001
pa < .001
p ¼ .164 p ¼ .0001
pa < .0001
p < .001 p < .001
AAA ¼ abdominal aortic aneurysm, maximum aortic diameter 30 mm; OR ¼ odds ratio.
a Adjusted for age, sex, smoking, comorbidity (diabetes, hypertension, peripheral arterial disease), and medication (ACE-inhibitors, beta-
blockers, acetylsalicylic acid [ASA], and statins).
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of controls.2 Lawrence et al. found arteriomegaly to be a
strong predictor of familial aneurysms with as many as 36%
of patients with arteriomegaly having an affected ﬁrst
degree relative.14
There has been some interest in the signiﬁcance of
having a female relative with AAA compared with having a
male relative with AAA. This study found the prevalence of
AAA to be higher in participants related to female patients
with AAA than males. This conﬁrms the ﬁndings from
Northern Ireland reported by Badger et al.1 as opposed to
the ﬁndings in a similar, Finnish population.6 Darling and
colleagues15 found that female patients with AAA who also
had a female relative with AAA, had a markedly increased
risk of rupture. Together with the present ﬁndings, these
observations seem to support the theory put forward by
Tilson et al.,9 of a two gene model with a susceptibility
factor on the X chromosome together with another auto-
somal mutation. Alternatively, the ﬁndings support a
multifactorial genetic model with higher threshold of
affection in females compared with males. Further in-
vestigations of these theories require the additional in-
clusion of representative, population based female
probands.
Regarding the clinical implications for this ﬁnding, a
recent study from Scotland reported increased mortality
and morbidity related to aortic enlargement even below
30 mm, and found this condition to be statistically corre-
lated to family history of AAA.16 Whether this ﬁnding can be
reproduced in other populations remains to be elucidated.
On a more general level, it is not unreasonable to assume
that a larger aortic diameter increases the risk of developing
AAA and patients with even a small increase in diameter
might have an inborn risk of developing AAA, which could
make them more vulnerable to other known risk factors
such as smoking and hypertension. A large study including
re-screening of patients with sub-aneurysmal dilated aortas
might shed some light on this matter, but that is outside the
limits of this study.
In conclusion, it was found that the abdominal aortic
diameter was increased in ﬁrst degree relatives of patients
with AAA. This difference remained signiﬁcant after testing
for environmental confounders, and conﬁrms the presenceof a genetic component causing familial clustering of aortic
enlargement.
In addition, the prevalence of AAA was found to be
signiﬁcantly higher among ﬁrst degree relatives of female,
compared with male, patients with AAA.
Limitations
Familial history is based on the recall of the participants and
may be subject to information bias. It is possible that pa-
tients mainly know about aneurysms in the family because
of their surgery or symptoms, for example rupture. This
would skew the results towards mainly larger aneurysms
being linked to a family history, which would increase the
difference between the groups. However, no signiﬁcant
difference was found in AAA size between þFH and FH.
That fewer patients with AAA reported the diagnosis in, for
example fathers than in brothers, may partly be because of
less information on diagnosis and cause of death in earlier
generations. This would underestimate the true number of
aneurysms in families and could possibly bias the results
towards a decreased difference between the groups. A large
number of known and possible confounders were tested for,
but it is possible that residual confounders might have
inﬂuenced the results. A more detailed analysis of in-
teractions between confounders was not part of the current
study.
Another limitation is that the questionnaire was not
validated nor did it account for the number of affected
siblings. Moreover the response “unknown” was not
included, but it was expected, that participants with no
knowledge of family history of AAA (including participants
who were adopted or who lost contact with their parents)
would either answer “no” or decline to answer the ques-
tion. Such mis-classiﬁcation, however, tends to underesti-
mate the associations.
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